AI MEDICAL SERVICE INC. hereinafter AIM a medical startup specializing in the development of diagnostic endoscopic AI signed a joint research agreement with Mahidol University in Thailand hereinafter Mahidol on March 1 2024 and began research activities on April 1 2024.
AI MEDICAL SERVICE INC. hereinafter AIM a medical startup specializing in the development of diagnostic endoscopic AI is excited to announce the first instance of Singaporean regulatory review and device registration for an AIbased endoscopic diagnostic support device that operates within the stomach brand name Endoscopic image diagnosis support software gastroAImodel G.
AI Medical Service Inc. Completes First Regulatory Review and Device Registration of Gastric AI-based Endoscopic Diagnosis Support System from Singapore s HSA
- The endoscopic AI differentiates gastric lesions as neoplastic or non-neoplastic -TOKYO (BUSINESS WIRE) AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce the first instance of Singaporean regulatory review and device.
TOKYO, October 12, 2023 AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research agreement with Institute of Gastroenterology and Hepatology (hereinafter IGH) and will begin research activities on October 27, 2023. AIM is the first Japanese company to sign a joint research agreement with IGH in the field of endoscopic AI, and IGH is the first Vietnamese institute that AIM has collaborated with thus far